title: [Experience of use of prolit septo in the complex treatment of patients with urolithiasis].
abstract: The efficacy of phytogenic drug prolit septo in the complex treatment of patients with urolithiasis complicated by infectious-inflammatory process was evaluated. The effects of prolit septo were assessed by a comparative evaluation of the results of microbiological analysis of urine in 14 patients of main group and 12 patients of control group. Patients in both groups were matched by sex, age, and results of raiological, clinical, biochemical and microbiological methods of examination. For the treatment of 11 patients of the main group, prolit septo was applied in combination with standard anti-bacterial treatment, 3 patients received monotherapy with prolit septo within 3-6 weeks. The drug was administered at a dose of 1200 mg (2 capsules) 3 times a day. Twelve patients of the control group received only standard treatment. The duration of treatment in both groups was 1-2 weeks. It was found that combined therapy with prolit septo is more effective than standard antibacterial treatment. Against the background of combined therapy the disappearance of bacteriuria was noted in 54.5% of patients of main group compared with 8.3% of patients of control group.
authors.forename: Ė K
authors.initials: ĖK
authors.lastname: Ianenko
authors.forename: O V
authors.initials: OV
authors.lastname: Konstantinova
authors.forename: N V
authors.initials: NV
authors.lastname: Poliakov
authors.forename: V O
authors.initials: VO
authors.lastname: Elagin
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001437:Bacteriuria / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D013293:Enterococcus faecalis / Q000187:drug effects* / Q000502:physiology; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007710:Klebsiella Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D029803:Phyllanthus; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use; D052878:Urolithiasis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D010936:Plant Extracts; D003404:Creatinine